The effect of rhBMP-2 and PRP delivery by biodegradable β-tricalcium phosphate scaffolds on new bone formation in a non-through rabbit cranial defect model

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 8, 2013, Pages 1895-1903

  Lim, Hyun Pil ^a   Mercado Pagan, Angel E ^b   Yun, Kwi Dug ^a   Kang, Seong Soo ^a   Choi, Taek Hue ^a   Bishop, Julius ^b   Koh, Jeong Tae ^a   Maloney, William ^b   Lee, Kwang Min ^a   Yang, Yunzhi Peter ^b,c   Park, Sang Won ^a  

^a Chonnam National University   (South Korea)

^b STANFORD UNIVERSITY   (United States)

^c Stanford University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE FORMATION; CRANIAL BONE; CRANIAL DEFECTS; MICROCOMPUTED TOMOGRAPHY; PLATELET-RICH PLASMA; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 (RHBMP-2); TRI-CALCIUM PHOSPHATES; VERTICAL BONE AUGMENTATION;

COMPUTERIZED TOMOGRAPHY; DEFECTS; SCAFFOLDS (BIOLOGY);

BONE;

CALCIUM PHOSPHATE CERAMIC; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HISTOPATHOLOGY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; SKULL DEFECT; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIUM PHOSPHATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MALE; MODELS, ANIMAL; OSTEOGENESIS; PLATELET-RICH PLASMA; RABBITS; RECOMBINANT PROTEINS; SKULL; SKULL FRACTURES; TISSUE SCAFFOLDS;

ORYCTOLAGUS CUNICULUS;

EID: 84880776672     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4939-9     Document Type: Article

References (52)

1. Wayne DB, Trajtenberg CP, Hyman DJ. Tooth and periodontal disease: a review for the primary-care physician. South Med J. 2001;94:925-32.
2. Yang Y, Oh N, Liu Y, Chen W, Oh S, Appleford M, Kim S, Kim K, Park S, Bumgardner J, Haggard W, Ong J. Enhancing osseointegration using surface-modified titanium implants. JOM-J Min Met Mat Soc. 2006;58:71-6.
3. Chow LC. Calcium phosphate cements. Monogr Oral Sci. 2001;18:148-63.
4. LeGeros RZ. Calcium phosphates in oral biology and medicine. Monogr Oral Sci. 1991;15:1-201.
5. Story BJ, Wagner WR, Gaisser DM, Cook SD, Rust-Dawicki AM. In vivo performance of a modified CSTi dental implant coating. Int J Oral Maxillofac Implants. 1998;13:749-57.
6. Karande TS, Ong JL, Agrawal CM. Diffusion in musculoskeletal tissue engineering scaffolds: design issues related to porosity, permeability, architecture, and nutrient mixing. Ann Biomed Eng. 2004;32:1728-43.
7. Kim K, Yeatts A, Dean D, Fisher JP. Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng B. 2010;16:523-39.
8. Impens S, Schelstraete R, Luyten J, Mullens S, Thijs I, van Humbeeck J, Schrooten J. Production and characterisation of porous calcium phosphate structures with controllable hydroxyapatite/b-tricalcium phosphate ratios. Adv Appl Ceram. 2009;108:494-500.
9. Li X, Li D, Lu B, Tang Y. Design and fabrication of CAP scaffolds by indirect solid free form fabrication. Rapid Prototyp J. 2005;11:312-8.
10. Mondrinos MJ, Dembzynski R, Lu L, Byrapogu VKC, Wootton DM, Lelkes PI, Zhou J. Porogen-based solid freeform fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineering. Biomaterials. 2006;27:4399-408.
11. Vivanco J, Aiyangar A, Araneda A, Ploeg H-L. Mechanical characterization of injection-molded macro porous bioceramic bone scaffolds. J Mech Behav Biomed Mater. 2012;9:137-52.
12. Kang Y, Kim S, Khademhosseini A, Yang Y. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials. 2011;32:6119-30.
13. Kang Y, Scully A, Young DA, Kim S, Tsao H, Sen M, Yang Y. Enhanced mechanical performance and biological evaluation of a PLGA coated b-TCP composite scaffold for load-bearing applications. Eur Polym J. 2011;47:1569-77.
14. Nguyen LH, Annabi N, Nikkhah M, Bae H, Binan L, Park S, Kang Y, Yang Y, Khademhosseini A. Vascularized bone tissue engineering: approaches for potential improvement. Tissue Eng B. 2012;18(5):363-82.
15. Yang Y, Kang Y, Sen M, Park S. Bioceramics in tissue engineering. In: Burdick J, Mauck R, editors. Biomaterials for tissue engineering applications: a review of the past and future trends. New York: Springer Wien; 2011. p. 179-208.
16. Wozney JM. The potential role of bone morphogenetic proteins in periodontal reconstruction. J Periodontol. 1995;66:506-10.
17. Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM, Kerns KM, Helm GA. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg-Spine. 1999;90:109-14.
18. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M, Ghivizzani SC, Robbins PD, Evans CH. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther. 2000;7:734-9.
19. Forslund C. BMP treatment for improving tendon repair. Acta Orthop. 2003;74:1-30.
20. Lieberman JR, Daluiski A, Stevenson S, Wu L, Mcallister P, Lee YP, Kabo JM, Finerman GAM, Berk AJ, Witte ON. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg. 1999;81:905-17.
21. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
22. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol. 2002;250:231-50.
23. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J. 2007;7:235-9.
24. Tazaki J, Murata M, Akazawa T, Yamamoto M, Ito K, Arisue M, Shibata T, Tabata Y. BMP-2 release and dose-response studies in hydroxyapatite and β-tricalcium phosphate. Biomed Mater Eng. 2009;19:141-6.
25. Xu XL, Lou J, Tang T, Ng KW, Zhang J, Yu C, Dai K. Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. J Biomed Mater Res B. 2005;75B:289-303.
26. Ruhé PQ, Boerman OC, Russel FGM, Spauwen PHM, Mikos AG, Jansen JA. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release. 2005;106:162-71.
27. Jeon O, Song SJ, Yang HS, Bhang S-H, Kang S-W, Sung MA, Lee JH, Kim B-S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun. 2008;369:774-80.
28. Gumieiro EH, Abrahão M, Jahn RS, Segretto H, Alves MT, Nannmark U, Granström G, Dib LL. Platelet-rich plasma in bone repair of irradiated tibiae of Wistar rats. Acta Cir Bras. 2010;25:257-63.
29. Yamada Y, Ueda M, Hibi H, Nagasaka T. Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and platelet-rich plasma: from basic research to clinical case study. Cell Transpl. 2004;13:343-55.
30. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225-8.
31. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol. 1998;85:638-46.
32. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent 2001;13:487-93, quiz 487-93.
33. Liu Y, Kim J-H, Young D, Kim S, Nishimoto SK, Yang Y. Novel template-casting technique for fabricating β-tricalcium phosphate scaffolds with high interconnectivity and mechanical strength and in vitro cell responses. J Biomed Mater Res A. 2009;92A:997-1006.
34. Hokugo A, Ozeki M, Kawakami O, Sugimoto K, Mushimoto K, Morita S, Tabata Y. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng. 2005;11:1224-33.
35. Müller R, Rüegsegger P. Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture. Stud Health Technol Inf. 1997;40:61-79.
36. Lan Levengood SK, Polak SJ, Poellmann MJ, Hoelzle DJ, Maki AJ, Clark SG, Wheeler MB, Wagoner Johnson AJ. The effect of BMP-2 on micro- and macro-scale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity. Acta Biomater. 2010;6:3283-91.
37. Murai M, Sato S, Fukase Y, Yamada Y, Komiyama K, Ito K. Effects of different sizes of β-tricalcium phosphate particles on bone augmentation within a titanium cap in rabbit calvarium. Dent Mater J. 2006;25:87-96.
38. Ruhé PQ, Kroese-Deutman HC, Wolke JGC, Spauwen PHM, Jansen JA. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials. 2004;25:2123-32.
39. Wada T, Hara K, Ozawa H. Ultrastructural and histochemical study of β-tricalcium phosphate resorbing cells in periodontium of dogs. J Periodontal Res. 1989;24:391-401.
40. Sánchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants. 2003;18:93-103.
41. Plachokova AS, Van Den Dolder J, Stoelinga PJ, Jansen JA. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res. 2006;17:305-11.
42. Plachokova AS, Van Den Dolder J, Stoelinga PJ, Jansen JA. Early effect of platelet-rich plasma on bone healing in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res. 2007;18:244-51.
43. Kovács K, Velich N, Huszár T, Szabó G, Semjén G, Reiczigel J, Suba Z. Comparative study of β-tricalcium phosphate mixed with platelet-rich plasma versus β-tricalcium phosphate, a bone substitute material in dentistry. Acta Vet Hung. 2003;51:475-84.
44. Poeschl PW, Ziya-Ghazvini F, Schicho K, Buchta C, Moser D, Seemann R, Ewers R, Schopper C. Application of platelet-rich plasma for enhanced bone regeneration in grafted sinus. J Oral Maxillofac Surg. 2012;70:657-64.
45. Sammartino G, Tia M, Marenzi G, di Lauro AE, D'Agostino E, Claudio PP. Use of autologous platelet-rich plasma (PRP) in periodontal defect treatment after extraction of impacted mandibular third molars. J Oral Maxillofac Surg. 2005;63:766-70.
46. Cabbar F, Güler N, Kürkcü M, Işeri U, Şençift K. The effect of bovine bone graft with or without platelet-rich plasma on maxillary sinus floor augmentation. J Oral Maxillofac Surg. 2011;69:2537-47.
47. Thorwarth M, Wehrhan F, Schultze-Mosgau S, Wiltfang J, Schlegel KA. PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation. Bone. 2006;38:30-40.
48. Boyan BD, Schwartz Z, Patterson TE, Muschler G. Clinical use of platelet-rich plasma in orthopaedics. Am Acad Orthop Surg Now. 2007;1:44-6.
49. Araújo MG, Sonohara M, Hayacibara R, Cardaropoli G, Lindhe J. Lateral ridge augmentation by the use of grafts comprised of autologous bone or a biomaterial. An experiment in the dog. J Clin Periodontol. 2002;29:1122-31.
50. Sartori S, Silvestri M, Forni F, Icaro Cornaglia A, Tesei P, Cattaneo V. Ten-year follow-up in a maxillary sinus augmentation using anorganic bovine bone (Bio-Oss). A case report with histomorphometric evaluation. Clin Oral Implants Res. 2003;14:369-72.
51. Schmid J, Hämmerle CHF, Flückiger L, Winkler JR, Olah AJ, Gogolewskiz S, Lang NP. Blood-filled spaces with and without filler materials in guided bone regeneration. A comparative experimental study in the rabbit using bioresorbable membranes. Clin Oral Implants Res. 1997;8:75-81.
52. Okazaki K, Shimizu Y, Xu H, Ooya K. Blood-filled spaces with and without deproteinized bone grafts in guided bone regeneration. Clin Oral Implants Res. 2005;16:236-43. and Skin Diseases